GO Term | Evidence Code | PMID |
---|---|---|
response to toxic substance | ||
axonogenesis | ||
intermediate filament bundle assembly | ||
anterograde axonal transport | ||
intermediate filament organization |
GO Term | Evidence Code | PMID |
---|---|---|
intermediate filament | ||
presynaptic intermediate filament cytoskeleton | ||
neurofilament | ||
axon | ||
cholinergic synapse |
GO Term | Evidence Code | PMID |
---|---|---|
protein-macromolecule adaptor activity | ||
protein domain specific binding | ||
structural constituent of postsynaptic intermediate filament cytoskeleton | ||
identical protein binding | ||
protein-containing complex binding |
Location | References |
---|---|
DO ID | Disease Name | Source |
---|---|---|
DOID:0050328 | congenital hypothyroidism | |
DOID:0050433 | fatal familial insomnia | |
DOID:0080294 | Charcot-Marie-Tooth disease dominant intermediate G | |
DOID:0080600 | COVID-19 | |
DOID:0080832 | mild cognitive impairment | |
DOID:0110149 | Charcot-Marie-Tooth disease type 1F | |
DOID:0110165 | Charcot-Marie-Tooth disease type 2E | |
DOID:10595 | Charcot-Marie-Tooth disease | |
DOID:10652 | Alzheimer's disease | |
DOID:11446 | sciatic neuropathy |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025